ANI PHARMACEUTICALS INC — Director's Dealing 2021

Apr 1, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2021-03-29

Reporting Person: CAREY STEPHEN P. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-29	Common Stock	F	953	$32.68	Disposed	116662	Direct
2021-03-31	Common Stock	F	508	$36.14	Disposed	116154	Direct

Footnotes

F1: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,113 shares of restricted stock, the grant of which was previously reported.

F2: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,657 shares of restricted stock, the grant of which was previously reported.